Intravenous zoledronate for postmenopausal osteoporosis

To determine the efficacy and safety of zoledronic acid therapy in the prevention and treatment of postmenopausal osteoporosis compared to placebo or active comparator (other bisphosphonates).

This is a protocol.

Share/Save